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Photonic biosensors that use optical resonances to 
amplify biological signals associated with the adsorption 
of low-index biological markers offer high-sensitivity 
detection capability, real-time readout, and scalable low-
cost fabrication. However, they lack inherent target 
specificity and can be sensitive to temperature variations 
and other noise sources. In this letter, we introduce a 
concept of the High Contrast Probe Cleavage Detection 
(HCPCD) mechanism, which makes use of the dramatic 
optical signal amplification caused by cleavage of large 
numbers of high-contrast nanoparticle labels instead of 
the adsorption of low-index biological molecules. We 
illustrate numerically the HCPCD detection mechanism 
with an example of a silicon ring resonator as an optical 
transducer with gold and silicon nanoparticles as high-
contrast labels. Simulations show that it is possible to 
detect a single cleavage-event by monitoring spectral 
shifts of micro-ring resonances. Furthermore, detection 
specificity and signal amplification can be achieved 
through the use of collateral nucleic acid cleavage caused 
by enzymes such as CAS12a and CAS13 after binding to a 
target DNA/RNA sequence. 
In recent months, the need for a step-change in sensing 
technology to meet the challenges of the 21st century has 
been highlighted by the ongoing SARS-CoV-2 pandemic. 
Achieving high sensitivity in optical biosensors is a 
fundamentally difficult problem, as the sensitivity of any 
readout is limited by the small difference in optical 
properties between water (with refractive index of 1.33 in 
the visible range) and biomolecules (typically having 
refractive index of ~1.45). Target selectivity is even harder 
to achieve due to a comparable optical response induced by 
the adsorption of different biomolecules. However, 
biological machinery, such as the DNA primers and enzymes 
used for the polymerase chain reaction (PCR), routinely 
operates near single molecule concentrations and with very 
high selectivity [1]. In particular, clustered regularly 
interspaced short palindromic repeats (CRISPR)-associated 
systems serve as a defense mechanism against infection in 
prokaryotes, and are capable of site-specific cleavage of 
target (deoxy)ribonucleic acids (DNA/RNA) followed by 
non-specific cleavage of nucleic acids. Previous work in viral 
detection has shown that CRISPR CAS12a and CAS13 
biological machinery can be harnessed to detect specific 
viral RNA or DNA strands [2,3], including recent efforts that 
have successfully shown SARS-CoV-2 detection [4,5]. 
CRISPR-based sensing techniques typically rely on 
measuring changes in the fluorescent response of probes 
(achieved via DNA/RNA oligo-probe cleavage to separate a 
quencher and a fluorophore), and thus require nucleic acid 
pre-amplification (e.g. PCR, LAMP) to reach attomolar 
sensitivity [6].  In principle, CRISPR-enabled single molecule 
detection is feasible, as a single CRISPR complex, activated 
by the hybridization of viral RNA/DNA to CRISPR RNA/DNA, 
produces thousands of non-specific collateral cleavages. 
However, fluorescent readout sets the lower limit for 
sensitivity in the fM range [2], and the nucleic acid pre-
amplification process requires 1-3 hours of sample 
incubation, preventing real-time rapid screening.  
 
Fig. 1 Probe-Cleavage Detection combines CRISPR system specificity 
(a) with sensitive optical readout provided by optical micro-ring 
resonator (b) and amplification mechanism based on multiple 
nanoparticle probe cleavages triggered by every CRISPR complex 
activation (c).  Probe cleavage results in a resonance red shift in the 
spectrum (d) of the ring. 
Photonic biosensors that use micro-resonators as optical 
transducers offer a highly sensitive readout via monitoring 
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spectral shifts and intensity changes of narrow spectral 
resonances associated with excitation of resonator modes 
[7–9]. State-of-the-art chip-based photonic biosensors are 
capable of detecting antibodies when they bind to the 
antigen-functionalized resonator surfaces, as well as protein 
molecules and single viruses [10–14]. Detection sensitivity 
can be dramatically enhanced by using a combination of 
micro-resonators with high quality-factor photonic modes 
and metal nanoparticles supporting surface plasmon 
resonances [15–18], as well as using self-referenced sensor 
designs [19,20]. Molecular selectivity can be achieved via 
sensor surface functionalization (e.g. with antibody-specific 
antigens or target-complementary single strands of DNA 
and RNA). However, the sensor inability to distinguish 
between a perfect nucleotide match and a partial match and 
high noise levels due to non-specific adsorption events 
present significant practical challenges [21].  
To achieve both, target selectivity and high sensitivity of 
detection, we propose to combine the detect-and-cleave 
biological mechanism of CRISPR systems with the robust 
and sensitive optical readout provided by a silicon photonic 
micro-ring resonator sensing platform (Fig. 1). A micro-
resonator-based probe cleavage detection system needs to 
be functionalized with one or multiple nanoparticle probes, 
tethered onto a micro-resonator surface by DNA or RNA 
strands. If these probes are made of high-index metal or 
semiconductor material, the removal of even a single 
particle introduces a significant change in the resonator 
transmission spectrum, which can be sensed by the optical 
interrogation circuit. This is a key difference between the 
proposed HCPCD scheme and conventional approaches, 
which rely on the adsorption/capture of a low-index target 
molecule to generate a signal detected via the associated 
micro-resonator spectrum change. The probe removal can 
be achieved by designing the probe to be cleaved directly by 
the target analyte, or to be cleaved by a cleaving agent that 
has a specific detection mechanism for the target analyte. 
Once activated, the cleaving agent removes probes from the 
micro-resonator surface, leading to a detectable signal (Fig. 
1). CRISPR Cas12 and Cas13 have been previously shown to 
cleave probes from a solid support in fluorescence-based 
viral diagnostic assay [22]. It should be noted that target 
molecules may be labeled with high contrast particles in the 
standard adsorption sensing architectures, nevertheless, 
this requires an additional binding step, which may 
significantly increase the sample processing time, and may 
reduce detection sensitivity and specificity. 
We estimated numerically the optical effect of the removal 
of either a single or multiple high-contrast nanoparticles 
from a surface of a microring resonator, which is often used 
as an integrated optical transducer in on-chip (bio)-
chemical sensing platforms. The Si microring supports high-
quality-factor whispering-gallery (WG) modes, whose 
spectral positions and quality factors are sensitive to the 
changes in the ring nano-environment [23,24]. First, we 
used the Finite Difference Eigenmode solver (Lumerical 
MODE package) to calculate the spectral shift and the optical 
loss of a transverse-electric (TE) WG mode of a 20 micron 
diameter microring in a 1.55-micron band, which is caused 
by the cleavage of a tethered nanoparticle (Fig. 2). Figure 2a 
illustrates the difference in the WG mode electric field 
profile in the microring cross-section before and after a 
single 10 nm radius gold (Au) nanoparticle is cleaved from 
its surface. Cleaving a particle off the resonator surface 
changes not only the local optical mode field profile but also 
the local effective index, leading to a change in spectral 
characteristics, including the resonant frequency and the 
optical loss (Fig. 2b). Since larger nanoparticles disturb the 
microring mode profile to a larger extent than smaller ones, 
cleavage of progressively larger Au nanoparticles generates 
larger resonance shifts. Our simulations predict blue shift of 
the WG mode resonant frequencies caused by the 
attachment of an Au nanoprobe, which is consistent with 
previous observations [25]. Accordingly, cleavage of an Au 
particle should result in a WG mode resonance redshift. 
Cleavage of dielectric nanoparticle probes can also be used 
as the detection mechanism. However, as shown in Fig. 2C 
for the case of a Si nanoparticle, the particle-induced mode 
redshift is an order of magnitude smaller than a blue shift 
caused by an Au probe of the same size, while the optical 
loss is negligible.  
 
Fig. 2  (a) Electric field intensity profiles for the fundamental TE mode 
in a 500 nm wide and 220 nm thick strip silicon on insulator (SOI) 
waveguide in water before and after cleavage of a single 10-nm radius 
Au probe. (b-c) Spectral characteristics of a WG mode in a 20-micron 
diameter microring formed by looping the SOI waveguide, decorated 
by probes of varying size and material. (b) WG mode wavelength blue 
shift and optical loss caused by adding a single Au probe to the ring as a 
function of probe size. (c) WG mode wavelength redshift caused by a Si 
probe as a function of probe size (loss is negligible). In all the 
simulations, the probes are located 20 nm away from the ring surface.  
To estimate the effect of the cleavage of multiple probes 
from a microring initially decorated by multiple Au 
nanoparticles, we performed three-dimensional finite 
difference time domain calculations of transmission spectra 
of a 20 micron diameter Si micro-ring resonator side-
coupled to a bus Si waveguide via an 80nm gap (FDTD 
Lumerical package). The microring is initially decorated by 
fifty 10 nm radius Au probes and is excited by the 
fundamental TE guided mode of the bus waveguide. The 
signal transmitted through the waveguide exhibits narrow 
spectral dips at the wavelengths corresponding to WG mode 
resonances in the ring (Fig. 3a,b). Our calculations show that 
the resonant spectral features are progressively shifted to 
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longer wavelengths as more and more probes are removed 
from the microring surface, as would happen during 
cleavage in experimental conditions (Fig. 3a-c). Figure 3d 
shows a characteristic electric field distribution in a 
waveguide-coupled microring resonator. 
We note that the wavelength shift predicted in our MODE 
simulations for a single 10 nm radius Au probe removal 
(10.68 pm) agrees qualitatively with the shift predicted by 
the 3D FDTD simulations (7.05 pm per particle on average). 
Importantly, this shift is about 5 times larger than the 
minimum shift that can be detected experimentally by using 
standard microring sensor architectures [9]. The practical 
limits of detection and time response in such a system may 
be determined by the diffusion rate of activated CRISPR 
complexes to the probe cleavage sites [26]. However, we 
have previously shown that WG mode resonators decorated 
by Au probes can capture biomolecules via optical trapping, 
reducing the detection time by two orders of magnitude 
beyond what can be expected due to diffusion [16], and 
similar enhancements have been observed in other 
resonator systems [27].  
 
 Fig. 3 (a) Transmission spectrum of a 20 micron diameter micro-ring 
resonator side-coupled to a one bus Si waveguide with the same 
parameters as in Fig. 2, initially decorated by 50 10 nm-radius Au 
probes located randomly around the ring circumference 20 nm away 
from its surface. The spectrum shifts as the number of attached probes 
is reduced to 26. (b) A magnified view of one of the WG mode 
resonances in (a). (c) The wavelength shifts for the three spectral dips 
in Fig. 3a as a function of the number of cleaved Au probes.  (d) An 
electric field distribution in the system calculated at the wavelength of 
1550 nm. 
Silicon photonic sensors have been demonstrated to be very 
scalable via production in standard silicon photonic 
processes [28,29], allowing for low cost and multiplexing of 
multiple tests on the same analyte via microarray printing 
of functionalization chemistry onto individual rings. 
Detection sensitivity and specificity can also be increased by 
monitoring both TE and TM polarized modes supported by 
the microring [30]. Finally, the HCPCD approach is 
completely general, and can be combined with other optical 
transducers (e.g. surface plasmon resonance sensors or 
Mach-Zehnder interferometers), as well as with electrical 
chip-based detection methods, and offers a pathway to 
highly sensitive real-time detection of biological molecules, 
viruses and other microorganisms. Any biosensing 
architectures based on analyte-induced enzymatic cleavage 
such as DNA-zyme biosensors [31] for sensing metal ions 
(as in water quality sensors) and Toehold Switch RNA 
sensors [32] are promising candidates for enhancement via 
HCPCD readout. More broadly, we hope the concept of 
communication between on-chip devices and biological 
systems via HCPCD can be generalized in the years to come 
as opto-biological nano-systems become more prevalent.  
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